Oncology Times - OncTimes Talk
OncTimes Talk features a variety of podcast series ranging from breaking news and oncology conference coverage to story round-ups and in-depth interviews with current experts and leaders in oncology.
- Update frequency
- every 4 days
- Average duration
- 13 minutes
- Episodes
- 199
- Years Active
- 2009 - 2025
Earliest Detection of Cancer by Artificial Intelligence Analysis of Circulating Cell-Free DNA Fragmentomes
00:13:46 |
Wed 29 May 2024
Bispecific Dual Checkpoint Blockade Extends Life & Slows Progression in Gastric & GE Junction Cancers
00:09:31 |
Thu 16 May 2024
Bispecific T-cell Engager Antibody Brings Deep, Durable Remissions in R/R Multiple Myeloma
00:15:07 |
Thu 02 May 2024
Exosome-Based Liquid Biopsy Promises Very Early Pancreatic Cancer Detection
00:12:50 |
Thu 02 May 2024
Polyepitopic Personalized Vaccine Brought Durable Immune Responses & Clinical Benefit in Resected Head & Neck Cancers
00:13:00 |
Thu 02 May 2024
Mesh-Supported Prepectoral Method of Breast Reconstruction After Breast Cancer Surgery
00:10:27 |
Mon 29 Apr 2024
Radiotherapy Boost Protects Young Patients With Early Breast Cancer, High Dose Boost Not Needed
00:08:38 |
Mon 29 Apr 2024
Breast-Conserving Therapy Effective for Ductal Carcinoma in Situ, But Questions Remain
00:15:40 |
Fri 26 Apr 2024
Three-Node Breast Cancer Spread: Most Patients Can Safely Avoid Axillary Dissection
00:09:42 |
Fri 26 Apr 2024
Artificial Intelligence Tool Predicts Postoperative Radiotherapy Lymphedema
00:34:36 |
Mon 15 Apr 2024
Neoadjuvant Pembrolizumab Improves High-Risk Early Breast Cancer Outcomes
00:08:47 |
Mon 15 Apr 2024
Preoperative Partial Breast Irradiation: Marked Benefit in Low-Risk Breast Cancer
00:09:00 |
Fri 12 Apr 2024
Adjuvant Atezolizumab: No Survival Benefit in Triple-Negative Breast Cancer
00:09:35 |
Thu 11 Apr 2024
Gene Test Shows Which Triple-Negative Breast Cancers Do Not Need Pre-Op Pembrolizumab
00:15:44 |
Wed 27 Mar 2024
Triple Therapy for Patients With Mutated FLT3 Gene in Acute Myeloid Leukemia
00:20:15 |
Fri 22 Mar 2024
World’s Largest Prostate Cancer Trial, STAMPEDE, Celebrates 20 Years of Progress
00:17:44 |
Wed 06 Mar 2024
Doublet Inhibitor Therapy Restrains Metastatic EGFR-Mutated NSCLC Progression
00:16:00 |
Mon 04 Mar 2024
Disclaimer: The podcast and artwork embedded on this page are the property of Oncology Times. This content is not affiliated with or endorsed by eachpod.com.